FORWARD PHARMA A/S's ticker is FWP and the CUSIP is 34986J105. A total of 24 filers reported holding FORWARD PHARMA A/S in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $733,000 | -53.2% | 34,000 | -67.4% | 0.04% | -56.0% |
Q4 2016 | $1,565,000 | -24.8% | 104,273 | +5.3% | 0.09% | +16.7% |
Q3 2016 | $2,080,000 | +12.1% | 99,053 | -3.0% | 0.08% | -19.6% |
Q2 2016 | $1,856,000 | +42.2% | 102,135 | +33.0% | 0.10% | +49.2% |
Q1 2016 | $1,305,000 | -1.9% | 76,785 | +9.7% | 0.06% | -11.0% |
Q4 2015 | $1,330,000 | -19.3% | 70,000 | 0.0% | 0.07% | +7.4% |
Q3 2015 | $1,649,000 | +23.6% | 70,000 | +99.7% | 0.07% | +38.8% |
Q2 2015 | $1,334,000 | -47.7% | 35,050 | -61.1% | 0.05% | -53.8% |
Q1 2015 | $2,550,000 | – | 90,060 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 1,387,853 | $29,145,000 | 5.49% |
Baupost Group | 5,367,300 | $112,660,000 | 1.60% |
Sio Capital Management, LLC | 85,108 | $1,786,000 | 1.23% |
Cormorant Asset Management, LP | 339,175 | $7,123,000 | 0.78% |
Assured Investment Management LLC | 1,344,495 | $28,234,000 | 0.65% |
Perceptive Advisors | 404,472 | $8,494,000 | 0.55% |
SPHERA FUNDS MANAGEMENT LTD. | 121,500 | $2,552,000 | 0.42% |
Orbimed Advisors | 798,000 | $16,750,000 | 0.19% |
Motley Fool Wealth Management, LLC | 69,495 | $1,459,000 | 0.15% |
Tekla Capital Management LLC | 136,547 | $2,867,000 | 0.11% |